NIOSH
HAZARD REVIEW
Health
Effects of Occupational Exposure |
|||||
|
|||||
Abbreviations |
|||||
ACGIH | American Conference of Governmental Industrial Hygienists | ||||
AMG | alpha-1-microglobulin | ||||
ATS | American Thoracic Society | ||||
BAL | bronchoalveolar lavage | ||||
BMG | beta-1-microglobulin | ||||
BMI | body mass index | ||||
°C | degree(s) Celsius | ||||
CA | chromosomal aberration(s) | ||||
cc | cubic centimeter | ||||
CDC | Centers for Disease Control and Prevention | ||||
CEN | European Standardization Committee | ||||
CFR | Code of Federal Regulations | ||||
CI | confidence interval | ||||
cm | centimeter(s) | ||||
COC | census occupation code | ||||
COPD | chronic obstructive pulmonary disease | ||||
Cu | copper | ||||
CV | coefficient of variation | ||||
__ CV |
pooled coefficient of variation |
||||
CWP | coal workers pneumoconiosis | ||||
DE | diatomaceous earth | ||||
DLCO | diffusing capacity of the lung for carbon monoxide | ||||
DNA | deoxyribonucleic acid | ||||
EPA | U.S. Environmental Protection Agency | ||||
°F | degree(s) Fahrenheit | ||||
FEV1 | forced expiratory volume in 1 second | ||||
FVC | forced vital capacity | ||||
g | gram(s) | ||||
HIV | human immunodeficiency virus | ||||
HLA | human leukocyte antigen | ||||
hprt | hypoxanthine-guanine phosphoribosyl transferase | ||||
hr | hour(s) | ||||
HSE | Health and Safety Executive (United Kingdom) | ||||
HVLV | high-velocity/low-volume | ||||
IARC | International Agency for Research on Cancer | ||||
ICD-9 | International Classification of Diseases, 9th edition | ||||
Ig | immunoglobulin | ||||
IGLV | immunoglobulin lambda-variable chain | ||||
ILO | International Labour Organization | ||||
IR | infrared absorption | ||||
ISO | International Organization for Standardization | ||||
Kα | electron ionization energy | ||||
KBr | potassium bromide | ||||
kv | kilovolt(s) | ||||
L | liter(s) | ||||
LOD | limit of detection | ||||
m | meter(s) | ||||
mA | milliamp(s) | ||||
MDHS | Methods for the Determination of Hazardous Substances (Health and Safety Executive, United Kingdom) | ||||
mg | milligram(s) | ||||
mg/m3 · yr | milligrams per cubic meter times years | ||||
min | minute(s) | ||||
ml | milliliter(s) | ||||
mm | millimeter(s) | ||||
mppcf | million particles per cubic foot | ||||
MSHA | Mine Safety and Health Administration | ||||
NAG | beta-N-acetyl-D-glucosaminidase | ||||
NIOSH | National Institute for Occupational Safety and Health | ||||
NIST | National Institute of Standards and Technology | ||||
NMRD | nonmalignant respiratory disease | ||||
NOES | National Occupational Exposure Survey | ||||
NOHSM | National Occupational Health Survey of Mining | ||||
NOMS | U.S. National Occupational Mortality Surveillance | ||||
NTM | nontuberculous mycobacteria | ||||
OR | odds ratio | ||||
OSHA | Occupational Safety and Health Administration | ||||
P | probability | ||||
PAP | pulmonary alveolar proteinosis | ||||
PAT | proficiency analytical testing | ||||
PDGF | platelet-derived growth factor | ||||
PEL | permissible exposure limit | ||||
PMR | proportionate mortality ratio | ||||
ppm | parts per million | ||||
PVC | polyvinyl chloride | ||||
RDS | respirable dust standard | ||||
REL | recommended exposure limit | ||||
RF | radio frequency | ||||
RFLP | restriction fragment length polymorphism | ||||
ROS | reactive oxygen species | ||||
RSD | relative standard deviation | ||||
___ RSD |
pooled relative standard deviation |
||||
SCE | sister chromatid exchange | ||||
SCG | single cell gel/comet | ||||
SIC | standard industrial classification | ||||
SiO2 | silicon dioxide | ||||
SIR | standardized incidence ratio | ||||
SMR | standardized mortality ratio | ||||
SRR | standardized rate ratio | ||||
TGF | transforming growth factor | ||||
TB | pulmonary tuberculosis | ||||
THF | tetrahydrofuran | ||||
TWA | time-weighted average | ||||
U.K. | United Kingdom | ||||
U.S. | United States | ||||
VC | vital capacity | ||||
WASP | Workplace Analysis Scheme for Proficiency | ||||
WHO | World Health Organization | ||||
wk | week(s) | ||||
XRD | X-ray diffraction | ||||
yr | year(s) | ||||
µg | microgram(s) | ||||
µm | micrometer(s) | ||||
% | percent | ||||
Glossary | |||||
Aerodynamic diameter
Chronic obstructive pulmonary disease (COPD)
Confidence interval (CI), confidence limits
Crystalline silica (or free silica)
Proportionate mortality ratio (PMR)
Scleroderma (progressive systemic sclerosis)
|
|||||
|
|||||
|